高级检索
当前位置: 首页 > 详情页

A population-based characterization study of \nanti-mitochondrial M2 antibodies and its consistency with anti-mitochondrial antibodies

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Lab Med, Guangzhou, Peoples R China [2]Guangzhou Univ Chinese Med, Affiliated Hosp 2, State Key Lab Dampness Syndrome Chinese Med, Guangzhou, Peoples R China [3]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Intellectual Property Management & Transfer Ctr, Guangzhou, Peoples R China [4]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Key Lab Chinese Med Prevent & Treat, Guangzhou, Peoples R China
出处:
ISSN:

关键词: antimitochondrial antibody subtype M2 (AMA-M2) primary biliary cholangitis population characteristics risk factors

摘要:
Objective: This study aims to estimate the prevalence of anti-mitochondrial antibody subtype M2 (AMA-M2) and assess its consistency with AMA in a general population.Methods: A total of 8954 volunteers were included to screen AMA-M2 using enzyme-linked immunosorbent assay. Sera with AMA-M2 >50 RU/mL were further tested for AMA using an indirect immunofluorescence assay.Results: The population frequency of AMA-M2 positivity was 9.67%, of which 48.04% were males and 51.96% were females. The AMA-M2 positivity in males had a peak and valley value of 7.81% and 16.88% in those aged 40 to 49 and =70 years, respectively, whereas it showed a balanced age distribution in females. Transferrin and immunoglobulin M were the risk factors for AMA-M2 positivity and exercise was the only protective factor. Of 155 cases with AMA-M2 >50 RU/mL, 25 cases were AMA-positive, with a female-to-male ratio of 5.25:1. Only 2 people, with very high AMA-M2 of 760 and >800 RU/mL, met the diagnostic criteria of primary biliary cholangitis (PBC), making the prevalence of PBC 223.36 per million in southern China.Conclusion: We found that AMA-M2 has a low coincidence rate with AMA in the general population. A new decision-making point for AMA-M2 is needed to improve consistency with AMA and diagnostic accuracy.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 4 区 医学
小类 | 4 区 医学实验技术
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学实验技术
JCR分区:
出版当年[2021]版:
Q4 MEDICAL LABORATORY TECHNOLOGY
最新[2023]版:
Q4 MEDICAL LABORATORY TECHNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Lab Med, Guangzhou, Peoples R China [2]Guangzhou Univ Chinese Med, Affiliated Hosp 2, State Key Lab Dampness Syndrome Chinese Med, Guangzhou, Peoples R China
通讯作者:
通讯机构: [1]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Lab Med, Guangzhou, Peoples R China [2]Guangzhou Univ Chinese Med, Affiliated Hosp 2, State Key Lab Dampness Syndrome Chinese Med, Guangzhou, Peoples R China [4]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangdong Prov Key Lab Chinese Med Prevent & Treat, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2020 今日访问量:0 总访问量:646 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号